McCoy The cohort included 351,913 adults aged 21 years and older with type 2 diabetes and moderate risk for CVD who filled an initial prescription for a GLP-1 drug , SGLT2 inhibitor, DPP-IV inhibitor or sulfonylurea from 2014 to 2021 (mean age, 65.3 years
Research suggests monitoring for signs of protein malnutrition, including muscle loss, fatigue, and weakened immune function
These data do not establish equivalent outcomes for compounded finished products
All content provided on Wellmedr.com is forinformational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.Always seek the advice of your physician or another qualified health provider with any questions regardinga medical condition.Prescriptions are issued by U.S.-licensed healthcare professionals and fulfilled by Mycelium Pharmacy, a licensed pharmacy partner
A minimum of 2 sessions per week of bodyweight or weighted resistance exercise is recommended